These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 15305887

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Diamicron MR once daily is effective and well tolerated in type 2 diabetes: a double-blind, randomized, multinational study.
    Drouin P.
    J Diabetes Complications; 2000; 14(4):185-91. PubMed ID: 11004426
    [Abstract] [Full Text] [Related]

  • 25. Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Roberts VL, Stewart J, Issa M, Lake B, Melis R.
    Clin Ther; 2005 Oct; 27(10):1535-47. PubMed ID: 16330290
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Gliclazide modified release.
    McGavin JK, Perry CM, Goa KL.
    Drugs; 2002 Oct; 62(9):1357-64; discussion 1365-6. PubMed ID: 12076188
    [Abstract] [Full Text] [Related]

  • 31. Glimepiride. A review of its use in the management of type 2 diabetes mellitus.
    Langtry HD, Balfour JA.
    Drugs; 1998 Apr; 55(4):563-84. PubMed ID: 9561345
    [Abstract] [Full Text] [Related]

  • 32. Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group.
    Rosenstock J, Samols E, Muchmore DB, Schneider J.
    Diabetes Care; 1996 Nov; 19(11):1194-9. PubMed ID: 8908379
    [Abstract] [Full Text] [Related]

  • 33. A comparison of efficacy and safety of vildagliptin and gliclazide in combination with metformin in patients with Type 2 diabetes inadequately controlled with metformin alone: a 52-week, randomized study.
    Filozof C, Gautier JF.
    Diabet Med; 2010 Mar; 27(3):318-26. PubMed ID: 20536495
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea.
    Lukashevich V, Del Prato S, Araga M, Kothny W.
    Diabetes Obes Metab; 2014 May; 16(5):403-9. PubMed ID: 24199686
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Glucose-lowering effects and low risk of hypoglycemia in patients with maturity-onset diabetes of the young when treated with a GLP-1 receptor agonist: a double-blind, randomized, crossover trial.
    Østoft SH, Bagger JI, Hansen T, Pedersen O, Faber J, Holst JJ, Knop FK, Vilsbøll T.
    Diabetes Care; 2014 Jul; 37(7):1797-805. PubMed ID: 24929431
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Gliclazide monotherapy increases risks of all-cause mortality and has similar risk of acute myocardial infarction and stroke with glimepiride monotherapy in Korean type 2 diabetes mellitus.
    Cho EH, Han K, Kim B, Lee DH.
    Medicine (Baltimore); 2020 Jul 17; 99(29):e21236. PubMed ID: 32702900
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of sitagliptin/metformin fixed-dose combination compared with glimepiride in patients with type 2 diabetes: A multicenter randomized double-blind study.
    Kim SS, Kim IJ, Lee KJ, Park JH, Kim YI, Lee YS, Chung SC, Lee SJ.
    J Diabetes; 2017 Apr 17; 9(4):412-422. PubMed ID: 27229178
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.